Your browser doesn't support javascript.
loading
Clinical features of patients with MTAP-deleted bladder cancer.
De Souza, Andre L; Mega, Anthony E; Douglass, John; Olszewski, Adam J; Gamsiz Uzun, Ece D; Uzun, Alper; Chou, Charissa; Duan, Fenghai; Wang, Jinyu; Ali, Amin; Golijanin, Dragan J; Holder, Sheldon L; Lagos, Galina G; Safran, Howard; El-Deiry, Wafik S; Carneiro, Benedito A.
Afiliação
  • De Souza AL; Division of Hematology Oncology, Legorreta Cancer Center at Brown University, Lifespan Cancer Institute Providence RI, United States.
  • Mega AE; Division of Hematology Oncology, Legorreta Cancer Center at Brown University, Lifespan Cancer Institute Providence RI, United States.
  • Douglass J; Division of Hematology Oncology, Legorreta Cancer Center at Brown University, Lifespan Cancer Institute Providence RI, United States.
  • Olszewski AJ; Division of Hematology Oncology, Legorreta Cancer Center at Brown University, Lifespan Cancer Institute Providence RI, United States.
  • Gamsiz Uzun ED; Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center Providence, RI, United States.
  • Uzun A; Center for Computational Molecular Biology, Brown University Providence RI, United States.
  • Chou C; Department of Pediatrics, The Warren Alpert Medical School, Brown University Providence, RI, United States.
  • Duan F; Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center Providence, RI, United States.
  • Wang J; Department of Biostatistics and Center for Statistical Sciences, Brown University School of Public Health Providence, RI, United States.
  • Ali A; Data Science Initiative, Brown University Providence, RI, United States.
  • Golijanin DJ; Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center Providence, RI, United States.
  • Holder SL; Urology Department, Minimally Invasive Urology Institute, The Miriam Hospital, The Warren Alpert Medical School of Brown University Providence, RI, United States.
  • Lagos GG; Division of Hematology Oncology, Legorreta Cancer Center at Brown University, Lifespan Cancer Institute Providence RI, United States.
  • Safran H; Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center Providence, RI, United States.
  • El-Deiry WS; Division of Hematology Oncology, Legorreta Cancer Center at Brown University, Lifespan Cancer Institute Providence RI, United States.
  • Carneiro BA; Division of Hematology Oncology, Legorreta Cancer Center at Brown University, Lifespan Cancer Institute Providence RI, United States.
Am J Cancer Res ; 13(1): 326-339, 2023.
Article em En | MEDLINE | ID: mdl-36777505
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Cancer Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Cancer Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos